KYTHERA Biopharmaceuticals Inc (NASDAQ:KYTH)

48.18
Delayed Data
As of Mar 27
 -0.06 / -0.12%
Today’s Change
29.50
Today|||52-Week Range
56.00
+38.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues13.0M19.7M0.000.00
 
 
 
Cost of Goods Sold1.1M1.3M0.000.00
 
 
 
Depreciation And Amortization54.0K635.0K223.0K--
 
 
 
 
 
Operating ExpensesGross Income11.8M17.8M-223.0K0.00
 
 
 
 
General Expenses22.6M53.7M49.8M78.9M
 
 
 
 
 
Research And Development15.8M43.2M34.0M47.8M
 
 
 
 
 
Total Operating Expenses23.8M55.6M50.1M78.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.8M-35.9M-50.1M-78.9M
 
 
 
 
 
Extraordinary Credit--1.2M0.00--
 
 
Extraordinary Charge--0.000.00-52.8M
 
 
Interest Expense On Debt304.0K0.002.0M4.2M
 
 
 
 
Other Expenses0.00-2.1M0.00-72.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.2M-36.8M-51.9M-135.6M
 
 
 
 
 
Net Income-11.2M-36.8M-51.9M-135.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.4M14.1M19.2M22.5M
 
 
 
 
 
Shares To Calculate EPS Diluted17.4M14.1M19.2M22.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.98-$2.62-$2.71-$6.04
 
 
 
 
 
EPS Diluted-$0.64-$2.62-$2.71-$6.04
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account